Logo image of ACU.CA

AURORA SOLAR TECHNOLOGIES IN (ACU.CA) Stock Fundamental Analysis

TSX-V:ACU - TSX Venture Exchange - CA05207J1084 - Common Stock - Currency: CAD

0.015  0 (0%)

Fundamental Rating

2

Overall ACU gets a fundamental rating of 2 out of 10. We evaluated ACU against 15 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of ACU have multiple concerns. ACU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACU had negative earnings in the past year.
In the past year ACU has reported a negative cash flow from operations.
In the past 5 years ACU always reported negative net income.
In the past 5 years ACU reported 4 times negative operating cash flow.
ACU.CA Yearly Net Income VS EBIT VS OCF VS FCFACU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1M -2M -3M -4M

1.2 Ratios

ACU has a Return On Assets of -31.30%. This is in the lower half of the industry: ACU underperforms 66.67% of its industry peers.
With a Return On Equity value of -55.78%, ACU perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
Industry RankSector Rank
ROA -31.3%
ROE -55.78%
ROIC N/A
ROA(3y)-60.95%
ROA(5y)-57.86%
ROE(3y)-85.08%
ROE(5y)-79.34%
ROIC(3y)N/A
ROIC(5y)N/A
ACU.CA Yearly ROA, ROE, ROICACU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

With an excellent Gross Margin value of 55.20%, ACU belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
ACU's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ACU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y13.48%
ACU.CA Yearly Profit, Operating, Gross MarginsACU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

2

2. Health

2.1 Basic Checks

ACU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACU has about the same amount of shares outstanding.
Compared to 5 years ago, ACU has more shares outstanding
ACU has a worse debt/assets ratio than last year.
ACU.CA Yearly Shares OutstandingACU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
ACU.CA Yearly Total Debt VS Total AssetsACU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

ACU has an Altman-Z score of -3.61. This is a bad value and indicates that ACU is not financially healthy and even has some risk of bankruptcy.
ACU has a worse Altman-Z score (-3.61) than 73.33% of its industry peers.
ACU has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
ACU has a better Debt to Equity ratio (0.01) than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -3.61
ROIC/WACCN/A
WACC8.22%
ACU.CA Yearly LT Debt VS Equity VS FCFACU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

2.3 Liquidity

ACU has a Current Ratio of 1.85. This is a normal value and indicates that ACU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.85, ACU is in line with its industry, outperforming 46.67% of the companies in the same industry.
A Quick Ratio of 0.60 indicates that ACU may have some problems paying its short term obligations.
The Quick ratio of ACU (0.60) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.6
ACU.CA Yearly Current Assets VS Current LiabilitesACU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

ACU shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.25%.
ACU shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.18%.
ACU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 90.22% yearly.
EPS 1Y (TTM)-8.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.74%
Revenue 1Y (TTM)-30.18%
Revenue growth 3Y80.16%
Revenue growth 5Y90.22%
Sales Q2Q%-66.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACU.CA Yearly Revenue VS EstimatesACU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ACU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACU.CA Price Earnings VS Forward Price EarningsACU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACU.CA Per share dataACU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 0.02 0.03

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACU!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AURORA SOLAR TECHNOLOGIES IN

TSX-V:ACU (7/10/2025, 7:00:00 PM)

0.015

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-27 2025-02-27
Earnings (Next)07-28 2025-07-28
Inst Owners10.14%
Inst Owner ChangeN/A
Ins Owners2.28%
Ins Owner ChangeN/A
Market Cap3.33M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.03
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -31.3%
ROE -55.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.2%
FCFM N/A
ROA(3y)-60.95%
ROA(5y)-57.86%
ROE(3y)-85.08%
ROE(5y)-79.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y31.07%
GM growth 5Y13.48%
F-Score3
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.99%
Cap/Sales 7.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.6
Altman-Z -3.61
F-Score3
WACC8.22%
ROIC/WACCN/A
Cap/Depr(3y)68.14%
Cap/Depr(5y)56.81%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-8.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-321.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.18%
Revenue growth 3Y80.16%
Revenue growth 5Y90.22%
Sales Q2Q%-66.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-231.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.03%
OCF growth 3YN/A
OCF growth 5YN/A